Details werden geladen...
Orforglipron Aids Weight Loss Across Menopausal Stages
Orforglipron, an oral non-peptide GLP-1 drug, helps women with obesity or overweight lose significantly more weight than placebo, regardless of menopausal stage.
Ähnliche Seiten
Fast Five Quiz: Confronting Obesity
https://reference.medscape.com/viewarticle/fast-five-quiz-confronting-obesity-2025a1000dru
GLP-1 Systematic Review Finds Weight Loss of Up to 24%
https://www.medscape.com/viewarticle/glp-1-systematic-review-finds-weight-loss-24-2026a1000yvqGLP-1 Meds Linked to Symptomatic Remission in UC
https://www.medscape.com/viewarticle/glp-1-meds-linked-symptomatic-remission-ulcerative-colitis-2026a1000wz3Not an ‘Easy Way Out’: Rethinking GLP-1 Stigma
https://www.medscape.com/viewarticle/not-easy-way-out-rethinking-glp-1-stigma-2026a1000wrw
Lilly's Foundayo Demonstrates Weight Loss Across Menopause Stages | 07.06.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/lillys-foundayo-demonstrates-weight-loss-across-menopause-stages-1036230382